Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in specialty pharmaceutical dealmaking

2.1. Introduction
2.2. Specialty pharmaceutical partnering over the years
2.3. Most active specialty pharmaceutical dealmakers
2.4. Specialty pharmaceutical partnering by deal type
2.5. Specialty pharmaceutical partnering by therapy area
2.6. Specialty pharmaceutical partnering by technology type
2.7. Deal terms for specialty pharmaceutical partnering
2.7.1 Specialty pharmaceutical partnering headline values
2.7.2 Specialty pharmaceutical deal upfront payments
2.7.3 Specialty pharmaceutical deal milestone payments
2.7.4 Specialty pharmaceutical royalty rates

Chapter 3 – Leading specialty pharmaceutical deals

3.1. Introduction
3.2. Top specialty pharmaceutical deals by value

Chapter 4 – Most active specialty pharmaceutical dealmakers

4.1. Introduction
4.2. Most active specialty pharmaceutical dealmakers
4.3. Most active specialty pharmaceutical partnering company profiles

Chapter 5 – Specialty pharmaceutical contracts dealmaking directory

5.1. Introduction
5.2. Specialty pharmaceutical contracts dealmaking directory

Chapter 6 – Specialty pharmaceutical dealmaking by technology type

Appendices

Appendix 1 – Specialty pharmaceutical deals by company A-Z
Appendix 2 – Specialty pharmaceutical deals by stage of development
Appendix 3 – Specialty pharmaceutical deals by deal type
Appendix 4 – Specialty pharmaceutical deals by therapy area
Appendix 5 – Deal type definitions
Appendix 6 – Further reading

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures


Figure 1: Specialty pharmaceutical partnering since 2016
Figure 2: Active specialty pharmaceutical dealmaking activity– 2016 to 2023
Figure 3: Specialty pharmaceutical partnering by deal type since 2016
Figure 4: Specialty pharmaceutical partnering by disease type since 2016
Figure 5: Specialty pharmaceutical partnering by technology type since 2016
Figure 6: Specialty pharmaceutical deals with a headline value
Figure 7: Specialty pharmaceutical deals with an upfront value
Figure 8: Specialty pharmaceutical deals with a milestone value
Figure 9: Specialty pharmaceutical deals with a royalty rate value
Figure 10: Top specialty pharmaceutical deals by value since 2016
Figure 11: Most active specialty pharmaceutical dealmakers 2016 to 2023